Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Guidi

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Plos One|February 7, 2019
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trialOriane Sottas, Monia Guidi, Benjamin Thieffry, et al.
Journal of Veterinary Pharmacology and Therapeutics|April 29, 2022
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beaglesOlivier Louis Levionnois, Andrea Barbarossa, Anisa Bardhi, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infectionsRaphaël Burger, Monia Guidi, Valérie Calpini, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2025
Population pharmacokinetics of bictegravir in real-world people with HIVPierre Ekobena, Myriam Briki, Kim Dao, et al.
Malaria Journal|April 20, 2019
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African childrenMonia Guidi, Thomas Mercier, Manel Aouri, et al.
Therapie|February 21, 2023
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION projectEvelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
BMC Pharmacology & Toxicology|September 27, 2023
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-studyPaul Thoueille, Margot Delfraysse, Pascal Andre, et al.
Jac-Antimicrobial Resistance|May 6, 2026
Characterization of isavuconazole pharmacokinetics and pharmacodynamics in a real-life cohortMonia Guidi, Jade Couchepin, Ilana Reinhold, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected IndividualsManel Aouri, Catalina Barcelo, Monia Guidi, et al.
Revue Medicale Suisse|October 18, 2023
[Risk assessment of drugs during breastfeeding]Evelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Plos One|February 7, 2019
Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trialOriane Sottas, Monia Guidi, Benjamin Thieffry, et al.
Journal of Veterinary Pharmacology and Therapeutics|April 29, 2022
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beaglesOlivier Louis Levionnois, Andrea Barbarossa, Anisa Bardhi, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infectionsRaphaël Burger, Monia Guidi, Valérie Calpini, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2025
Population pharmacokinetics of bictegravir in real-world people with HIVPierre Ekobena, Myriam Briki, Kim Dao, et al.
Malaria Journal|April 20, 2019
Population pharmacokinetics and pharmacodynamics of the artesunate-mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African childrenMonia Guidi, Thomas Mercier, Manel Aouri, et al.
Therapie|February 21, 2023
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION projectEvelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
BMC Pharmacology & Toxicology|September 27, 2023
Population pharmacokinetic analysis of lopinavir in HIV negative individuals exposed to SARS-CoV-2: a COPEP (COronavirus Post-Exposure Prophylaxis) sub-studyPaul Thoueille, Margot Delfraysse, Pascal Andre, et al.
Jac-Antimicrobial Resistance|May 6, 2026
Characterization of isavuconazole pharmacokinetics and pharmacodynamics in a real-life cohortMonia Guidi, Jade Couchepin, Ilana Reinhold, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected IndividualsManel Aouri, Catalina Barcelo, Monia Guidi, et al.
Revue Medicale Suisse|October 18, 2023
[Risk assessment of drugs during breastfeeding]Evelina Cardoso, Anaëlle Monfort, Ema Ferreira, et al.
Pageof 11